1. Home
  2. ISTR vs CABA Comparison

ISTR vs CABA Comparison

Compare ISTR & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$26.57

Market Cap

372.2M

Sector

Finance

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.97

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
CABA
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.2M
319.6M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
ISTR
CABA
Price
$26.57
$2.97
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$29.00
$14.57
AVG Volume (30 Days)
106.6K
2.3M
Earning Date
04-20-2026
03-16-2026
Dividend Yield
1.65%
N/A
EPS Growth
4.41
N/A
EPS
2.13
N/A
Revenue
N/A
N/A
Revenue This Year
$66.03
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$12.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.39
$0.99
52 Week High
$30.49
$3.78

Technical Indicators

Market Signals
Indicator
ISTR
CABA
Relative Strength Index (RSI) 34.29 46.38
Support Level $26.16 $2.11
Resistance Level $27.95 $3.34
Average True Range (ATR) 0.77 0.21
MACD -0.17 -0.06
Stochastic Oscillator 15.07 18.33

Price Performance

Historical Comparison
ISTR
CABA

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: